Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

326 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of soluble amyloid-β precursor protein assays as diagnostic CSF biomarkers for neurodegenerative diseases.
van Waalwijk van Doorn LJ, Koel-Simmelink MJ, Haußmann U, Klafki H, Struyfs H, Linning P, Knölker HJ, Twaalfhoven H, Kuiperij HB, Engelborghs S, Scheltens P, Verbeek MM, Vanmechelen E, Wiltfang J, Teunissen CE. van Waalwijk van Doorn LJ, et al. Among authors: verbeek mm. J Neurochem. 2016 Apr;137(1):112-21. doi: 10.1111/jnc.13527. Epub 2016 Jan 24. J Neurochem. 2016. PMID: 26748905 Free article.
Cerebrospinal fluid tau levels in frontotemporal dementia.
Verbeek MM, Pijnenburg YA, Schoonenboom NS, Kremer BP, Scheltens P. Verbeek MM, et al. Ann Neurol. 2005 Oct;58(4):656-7; author reply 657. doi: 10.1002/ana.20642. Ann Neurol. 2005. PMID: 16178027 No abstract available.
CSF neurofilament proteins in the differential diagnosis of dementia.
de Jong D, Jansen RW, Pijnenburg YA, van Geel WJ, Borm GF, Kremer HP, Verbeek MM. de Jong D, et al. Among authors: verbeek mm. J Neurol Neurosurg Psychiatry. 2007 Sep;78(9):936-8. doi: 10.1136/jnnp.2006.107326. Epub 2007 Feb 21. J Neurol Neurosurg Psychiatry. 2007. PMID: 17314187 Free PMC article.
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease.
Verwey NA, van der Flier WM, Blennow K, Clark C, Sokolow S, De Deyn PP, Galasko D, Hampel H, Hartmann T, Kapaki E, Lannfelt L, Mehta PD, Parnetti L, Petzold A, Pirttila T, Saleh L, Skinningsrud A, Swieten JC, Verbeek MM, Wiltfang J, Younkin S, Scheltens P, Blankenstein MA. Verwey NA, et al. Among authors: verbeek mm. Ann Clin Biochem. 2009 May;46(Pt 3):235-40. doi: 10.1258/acb.2009.008232. Epub 2009 Apr 2. Ann Clin Biochem. 2009. PMID: 19342441
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
Visser PJ, Verhey F, Knol DL, Scheltens P, Wahlund LO, Freund-Levi Y, Tsolaki M, Minthon L, Wallin AK, Hampel H, Bürger K, Pirttila T, Soininen H, Rikkert MO, Verbeek MM, Spiru L, Blennow K. Visser PJ, et al. Among authors: verbeek mm. Lancet Neurol. 2009 Jul;8(7):619-27. doi: 10.1016/S1474-4422(09)70139-5. Epub 2009 Jun 10. Lancet Neurol. 2009. PMID: 19523877
326 results